Video

Pioneering Oncologist Discusses Preventing Cancer

Dr. Maurie Markman sits down with Dr. Vincent T. DeVita, one of the most influential researchers and physicians in the cancer care arena.

Dr. Maurie Markman sits down with Dr. Vincent T. DeVita, one of the most influential researchers and physicians in the cancer care arena.

This is part III of a four-part interview.

View part I of the interview here

Part II here

Part IV here

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Outpatient CAR T-cell therapy has reduced hospital stays by two-thirds while maintaining safety for those with blood cancers, according to Dr. Olalekan Oluwole.
Dr. Masey Ross explains how biomarker testing, patient history, and quality-of-life concerns guide treatment decisions in metastatic breast cancer.
Dr. Paolo Tarantino shares how antibody-drug conjugates deliver more targeted chemo, and how the treatment lasts longer in the body vs traditional therapy.
Image of women with text.
The inMIND trial led to the FDA approval of Monjuvi with Revlimid and Rituxan for relapsed follicular lymphoma, showing benefits across diverse patients.
Clinical Trial Evaluating Monjuvi in Lymphoma Gives Lasting Responses
Survivors can find strength after cancer by focusing on goals, loved ones, and spiritual connection, especially during challenging or uncertain times.
Image of man with text.
Dr. Breelyn Wilky explains how vague symptoms and testing challenges delay GIST diagnoses
Mark Daniels, an 83-year-old veteran and former fighter pilot, was shocked by his lymphoma diagnosis because he maintained exceptional physical fitness.